4G5-32676-36820
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 977 / OR
- Registered
- 2021-08-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-27
Registered in v-safe
-
2021-08-27
Dose 1 — Pfizer-BioNTech
- 2021-08-27
-
2021-08-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-08-29
-
2021-08-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-09-03
- 2021-09-10
- 2021-09-19
-
2021-09-22
Dose 2 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-06
- 2021-10-15
- 2021-10-22
- 2021-10-27
- 2021-11-05
-
2022-03-23
Survey response — 6 months, dose 2MedDRA: Anaemia, Arthralgia, Haemoglobin decreased, Haemorrhage, Medical counselling, Postpartum state, Thrombosis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Hemorrhaged after birth, became anemic (hgb 8.7) and had excessive blood loss in clots at 2 weeks postpartum. Also having bad joint pain for the last month. · Healthcare visit (other): I had visits with my midwife and a pelvic ultrasound as well as blood work done.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-23
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-24
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-27 | Pfizer-BioNTech | No |
| 2 | 2021-09-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-23 | Successful 2022-03-24 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 6 months, dose 2
Symptoms: Hemorrhaged after birth, became anemic (hgb 8.7) and had excessive blood loss in clots at 2 weeks postpartum. Also having bad joint pain for the last month.
Healthcare visit (other): I had visits with my midwife and a pelvic ultrasound as well as blood work done.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Anaemia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Haemoglobin decreased | · | · | ✓ |
| SD | Haemorrhage | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release